William Hinshaw - Jan 28, 2022 Form 4 Insider Report for Axcella Health Inc. (AXLA)

Role
President and CEO, Director
Signature
By: /s/ Paul Fehlner, Attorney-in-Fact
Stock symbol
AXLA
Transactions as of
Jan 28, 2022
Transactions value $
-$27,393
Form type
4
Date filed
2/1/2022, 03:30 PM
Next filing
Feb 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXLA Common Stock Options Exercise +50K 50K Jan 28, 2022 Direct F1
transaction AXLA Common Stock Sale -$27.4K -16.6K -33.18% $1.65* 33.4K Jan 31, 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Restricted Stock Units Options Exercise $0 -50K -100% $0.00* 0 Jan 28, 2022 Common Stock 50K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of AXLA common stock.
F2 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.61 to $1.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The restricted stock units vested in full on January 28, 2022.